SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon divests 5.4% stake in Syngene International

07 Sep 2022 Evaluate

Biocon has divested 5.4 per cent stake in its research arm -- Syngene International -- for a little over Rs 1,220 crore through an open market transaction. According to bulk deal data available with the BSE, the company has sold a total of 21,789,164 shares, at an average price of Rs 560.04 apiece, in Syngene International.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

418.20 -0.20 (-0.05%)
01-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1869.50
Dr. Reddys Labs. 1337.40
Cipla 1457.50
Zydus Lifesciences 1108.85
Lupin 2396.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: